Abstract Over a third of the global population is affected by obesity, fatty liver disease (Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD), and its severe form, MASH (Metabolic Dysfunction-Associated Steatohepatitis), which can ultimately progress to hepatocellular carcinoma (HCC)
13 Conflict of interest The author has received payment for advisory boards and/or lectures from Allergan, AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi, Eli Lilly, Lexicon, MSD, NAPP, Novo Nordisk and Sanofi
These advanced computational approaches will improve risk assessment accuracy by accounting for real-world exposure scenarios
HSA and FSA accounts cover PlexusDx tirzepatide, making personalized therapy accessible to more patients
Preserving lean muscle mass during weight loss helps protect metabolic rate, maintain physical function, and improve long-term weight maintenance
Use the peptide cost calculator to compare monthly expenses across different compounds and protocols